University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service — Los Angeles, California

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service?

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service conducted?

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service has 1 clinical trials on record. Their work covers Solid Tumors.

Is University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service accredited by Crixeo Health?

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.